EDITH PEARSALL: Open Payments
NPI 1033255369 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,177 in 15 payments from 8 companies in 2025. Trend: 2023 $860 · 2024 $743 · 2025 $1,177
Food & beverage: $1,177
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $241 |
| Otsuka America Pharmaceutical, Inc. | 3 | $235 |
| Neurocrine BioSciences, Inc. | 3 | $181 |
| AstraZeneca Pharmaceuticals LP | 2 | $136 |
| Astellas Pharma US Inc | 1 | $124 |
| GlaxoSmithKline, LLC. | 1 | $111 |
| Paratek Pharmaceuticals, Inc. | 1 | $100 |
| Lilly USA, LLC | 2 | $50 |
Products named: Auvelity, REXULTI, INGREZZA, AIRSUPRA, Veozah, AREXVY, NUZYRA, MOUNJARO.
Industry payments across NC — which companies pay providers there.
